News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Dinesh Pendharkar: Advocacy needs to continue irrespective
Feb 16, 2025, 13:28

Dinesh Pendharkar: Advocacy needs to continue irrespective

Dinesh Pendharkar, Director of Oncology at Sarvodaya Hospital and Research Centre, Faridabad, shared a post on LinkedIn:

“Had the opportunity to discuss cancer programme for Madhya Pradesh with Dr. Mohan Yadav. Advocacy needs to continue irrespective. With the Governmental budget announcement district cancer care programme initiated by us in 2014 will now get a big boost.”

Dinesh Pendharkar: Advocacy needs to continue irrespective

More posts featuring Dinesh Pendharkar.

cancer Dinesh Pendharkar Madhya Pradesh Mohan Yadav OncoDaily Oncology
Special Coverage
Blog
May 1, 2025, 19:08
Jasmine Kamboj: Fantastic conversations on AI in Oncology with trailblazers
Blog
May 1, 2025, 18:56
Hadieh Eslampanah is Participating in the 17th CCI and SIOP Asia Riyadh 2025 Conference as a Board Member
Blog
May 1, 2025, 18:12
Alastair Lamb highlights BJUI session on AI and Medicolegal topics at AUA25
Blog
May 1, 2025, 18:05
Misty Dawn Shields: An amazing night at the "Evening of Promise" gala hosted by American Lung Association
Blog
May 1, 2025, 18:04
Karuna Ganesh reveals E. coli’s role in early-onset colorectal cancer Initiation at AACR25
Drugs
May 1, 2025, 17:54
Zongertinib breakthrough: Elizabeth McKenna highlights new study on HER2-driven cancers
Insight
May 1, 2025, 17:49
Miguel Bronchud shared insights on the tumor microenvironment in cancer progression
Opinion
May 1, 2025, 17:39
Daniel Flora: Letter to my new cancer patients - What I want you to know as we begin this journey
Insight
May 1, 2025, 17:30
Gustavo Viani: Supercharged Spinal Metastases SBRT-SIB Boost Scores High Local Control 
Blog
May 1, 2025, 17:29
Muhammad Shaalan Beg shared methods to reimagine patient-centric clinical trials at AACR25 - Moffitt Cancer Center
Blog
May 1, 2025, 17:15
Shaban Juma Shares Vital Insights on Lung Cancer and Its Primary Risk Factors - Cancer Fight Tanzania
Drugs
May 1, 2025, 17:14
Ana Velázquez Mañana highlights NEJM study by John Heymach on Zongertinib’s efficacy in HER2-Mutant NSCLC at AACR25